× Industry Reports Services Press Release Contact us About us

Asia Pacific Gene Editing Market Size By Technology (CRISPR/Cas9, Zinc Finger Nucleases (ZFNs), TALENs), By End-user (Biotech and Pharma Companies, Contract Research Organizations (CROs), Research Institutes), By Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), Industry Analysis Report, Country Outlook (Japan, China, India, Australia, South Korea, Malaysia, Thailand, Taiwan, Indonesia), Application Potential, Competitive Market Share & Forecast, 2020 - 2026
Published Date: November 2020 | Publisher: Graphical Research Report ID: GR1512 | Delivery : PDF  Request Free Sample

Report Content

Chapter 1   Methodology

1.1    Definition and forecast parameters

1.1.1    Definitions

1.1.2    Methodology and forecast parameters

1.2    Data sources

1.3    References & sources

1.3.1    Secondary

1.3.2    Primary

Chapter 2   Executive Summary

2.1    Asia Pacific gene editing industry summary, 2015 - 2026

2.1.1    Country trends

2.1.2    Application trends

2.1.3    Technology trends

2.1.4    End-user trends

Chapter 3   Industry Insights

3.1    Industry segmentation

3.2    Industry outlook, 2015 - 2026

3.3    Major factor analysis

3.3.1    Drivers

3.3.1.1    Rising R&D expenditure and growth of biotechnology

3.3.1.2    Increased funding for genetic research in Asia Pacific

3.3.1.3    Technology advancements in gene editing

3.3.1.4    Increasing demand for synthetic genes in Asia Pacific

3.3.2    Restraints & challenges

3.3.2.1    Stringent government regulations

3.3.2.2    Lack of public awareness in underdeveloped economies

3.4    COVID-19 impact analysis

3.5    Porter’s analysis

3.6    Competitive review, 2019

3.7    PEST analysis

Chapter 4   Asia Pacific Gene Editing Market Share, By Application

4.1    Key trends in Asia Pacific gene editing, by application

4.2    Cell line engineering

4.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.3    Animal genetic engineering

4.3.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.4    Plant genetic engineering

4.4.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.5    Others

4.5.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

Chapter 5   Asia Pacific Gene Editing Market Size, By Technology

5.1    Key trends in Asia Pacific gene editing, by technology

5.2    CRISPR/Cas9

5.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.3    Zinc Finger Nucleases (ZFNs)

5.3.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.4    TALENs

5.4.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.5    Others

5.5.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

Chapter 6   Asia Pacific Gene Editing Market Value, By End-user

6.1    Key trends in Asia Pacific gene editing, by end-user

6.2    Biotech and Pharma Companies

6.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

6.3    Contract Research Organizations (CROs)

6.3.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

6.4    Research Institutes

6.4.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

Chapter 7   Asia Pacific Gene Editing Market Forecast, By Country

7.1    Key trends in Asia Pacific gene editing, by country

7.2    China

7.2.1    Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.2.2    Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.2.3    Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.3    India

7.3.1    Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.3.2    Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.3.3    Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.4    Japan

7.4.1    Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.4.2    Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.4.3    Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.5    Australia

7.5.1    Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.5.2    Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.5.3    Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.6    South Korea

7.6.1    Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.6.2    Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.6.3    Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.7    Malaysia

7.7.1    Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.7.2    Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.7.3    Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.8    Thailand

7.8.1    Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.8.2    Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.8.3    Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.9    Taiwan

7.9.1    Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.9.2    Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.9.3    Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.10    Indonesia

7.10.1    Market estimates and forecast, by product, 2015 - 2026 (USD Million)

7.10.2    Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.10.3    Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.10.4    Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

Chapter 8   Company Profiles

8.1    Agilent Technologies, Inc.

8.1.1    Business overview

8.1.2    Financial data

8.1.3    Product landscape

8.1.4    Strategic outlook

8.2    Applied Stem Cell

8.2.1    Business overview

8.2.2    Financial data

8.2.3    Product landscape

8.2.4    Strategic outlook

8.3    Bio-Rad Laboratories

8.3.1    Business overview

8.3.2    Financial data

8.3.3    Product landscape

8.3.4    Strategic outlook

8.4    Beam Therapeutics

8.4.1    Business overview

8.4.2    Financial data

8.4.3    Product landscape

8.4.4    Strategic outlook

8.5    CRISPR Therapeutics

8.5.1    Business overview

8.5.2    Financial data

8.5.3    Product landscape

8.5.4    Strategic outlook

8.6    EMD Millipore (Merck KGaA)

8.6.1    Business overview

8.6.2    Financial data

8.6.3    Product landscape

8.6.4    Strategic outlook

8.7    GeneCopoeia

8.7.1    Business overview

8.7.2    Financial data

8.7.3    Product landscape

8.7.4    Strategic outlook

8.8    GenScript Corporation

8.8.1    Business overview

8.8.2    Financial data

8.8.3    Product landscape

8.8.4    Strategic outlook

8.9    Horizon Discovery Ltd

8.9.1    Business overview

8.9.2    Financial data

8.9.3    Product landscape

8.9.4    Strategic outlook

8.10    Integrated DNA Technologies Inc

8.10.1    Business overview

8.10.2    Financial data

8.10.3    Product landscape

8.10.4    Strategic outlook

8.11    Origene Technologies

8.11.1    Business overview

8.11.2    Financial data

8.11.3    Product landscape

8.11.4    Strategic outlook

8.12    Precision Biosciences

8.12.1    Business overview

8.12.2    Financial data

8.12.3    Product landscape

8.12.4    Strategic outlook

8.13    Takara Bio Inc

8.13.1    Business overview

8.13.2    Financial data

8.13.3    Product landscape

8.13.4    Strategic outlook

8.14    Thermo Fisher Scientific

8.14.1    Business overview

8.14.2    Financial data

8.14.3    Product landscape

8.14.4    Strategic outlook

8.15    Editas Medicine

8.15.1    Business overview

8.15.2    Financial data

8.15.3    Product landscape

8.15.4    Strategic outlook

8.16    Intellia Therapeutics

8.16.1    Business overview

8.16.2    Financial data

8.16.3    Product landscape

8.16.4    Strategic outlook

 


Premium Report

Have questions?
  • Inquire Before Buying
  • Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

     1-800-986-6917

     [email protected]